Acceliant Showcases Its eClinical Suite at BioPharma Asia Convention 2013

Bangalore, India, May 14, 2013 --(PR.com)-- Acceliant, a global technology provider of innovative clinical trial management solutions, showcased its clinical data management solutions and capabilities at the BioPharma Asia Convention 2013 in Singapore. At the event, Ven Thangaraj, CTO of Acceliant, and his team demonstrated the comprehensive features of the eClinical Suite and discussed the advantages of a single e-PRO/EDC system over modular and disparate systems.

Thanks to all the attendees whose presence made the event a huge success and the interest shown in the product and appreciate the insights provided is immensely valued.

Speaking on the success at the convention, Santhosh Nagaraj, Sales Head, said, "The convention was a great platform to expand our reach and make new connections with the global pharmaceutical and CRO firms. Several partnership opportunities, especially due to the growing demand for efficient and cost-effective clinical data management solutions are expected."

"Acceliant eClinical Suite boasts of integrated EDC/ePRO, UTB and trial management modules. Its advanced, user-friendly features like patient engagement, mobility, and multilingual support drive speed and efficiency across all phases of clinical trials. Customer interactions and insights gathered from experts at the convention will help boost the team's efforts to serve the life sciences industry better," emphasized Prashant Bhavaraju, Chief Marketing Officer.

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.